Paperpal Prime Logo

Anticancer Research : Impact Factor & More

eISSN: 1791-7530pISSN: 0250-7005

Aims and Scope of Anticancer Research

Anticancer Research is an independent international peer-reviewed medical journal published by the International Institute of Anticancer Research, addressing experimental and clinical topics in oncology. Issues are released monthly print and online (by Highwire Press), and an annual Index is also published. Anticancer Research was established in 1981 by John G. Delinassios. Less

Key Metrics

CiteScore
4.1
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.72
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Anticancer Research

Anticancer Research Journal Specifications

Overview
Publisher INT INST ANTICANCER RESEARCH
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1981
Website URLVisit website
View less

Planning to publish in Anticancer Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Anticancer Research

Targeting the LRIG2-PI3K/AKT/mTOR Axis to Induce Apoptosis: A Novel Antitumor Mechanism of Verbascoside in Endometrial Cancer Cells.
  • 1 Jul 2026
  • Anticancer research
Metabolic Reprogramming and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Mechanisms and Therapeutic Strategies.
  • 1 Jul 2026
  • Anticancer research
Rapidly Progressive Multiple Hepatic Hemangiomas Mimicking Angiosarcoma: A Case Report With Surgical and Interventional Management.
  • 1 Jul 2026
  • Anticancer research
Robot-assisted Complete Urinary Tract Exenteration for Multifocal Urothelial Carcinoma: Perioperative Management in Non-dialysis Patients.
  • 1 Jul 2026
  • Anticancer research
Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells via Inhibition of AKT Phosphorylation.
  • 1 Jul 2026
  • Anticancer research
Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab.
  • 1 Jul 2026
  • Anticancer research
Targeting the LRIG2-PI3K/AKT/mTOR Axis to Induce Apoptosis: A Novel Antitumor Mechanism of Verbascoside in Endometrial Cancer Cells.
  • 1 Jul 2026
  • Anticancer research
Metabolic Reprogramming and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Mechanisms and Therapeutic Strategies.
  • 1 Jul 2026
  • Anticancer research
Rapidly Progressive Multiple Hepatic Hemangiomas Mimicking Angiosarcoma: A Case Report With Surgical and Interventional Management.
  • 1 Jul 2026
  • Anticancer research
Robot-assisted Complete Urinary Tract Exenteration for Multifocal Urothelial Carcinoma: Perioperative Management in Non-dialysis Patients.
  • 1 Jul 2026
  • Anticancer research
Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells via Inhibition of AKT Phosphorylation.
  • 1 Jul 2026
  • Anticancer research
Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab.
  • 1 Jul 2026
  • Anticancer research

FAQs on Anticancer Research